Providence Therapeutics’ Sorenson on COVID-19 mRNA vaccine clinical trials, partnerships

Canadian biotech Providence Therapeutics CEO talks to Scrip on mRNA vaccines against COVID-19, cancer Shownotes – Providence Therapeutics CEO Brad Sorenson talks about his company’s plans for Phase II, III clinical trials for an mRNA vaccine as well as marketing and manufacturing partnerships with Biological E, Everest Medicines, Emergent Biosolutions and Northern RNA. He also discusses Providence’s m-RNA vaccines against cancer